1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Fertility Market in the US 2016-2020

Fertility Market in the US 2016-2020

  • January 2016
  • -
  • Infiniti Research Limited
  • -
  • 63 pages

Summary

Table of Contents

Search Inside

About Fertility

Couples with fertility issues are unable to conceive even after regular unprotected coitus (six months if the woman is over age 35). Female or male infertility factors account for one-third of the cases, where a couple is unable to conceive. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors.

In males, low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm can lead to infertility. In females, hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities can lead to infertility. Diagnosing the cause of infertility can be difficult but people with fertility issues have many treatment options depending on the underlying problem.

Technavio’s analysts forecast the fertility services market in the US to grow at a CAGR of 4.07% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the fertility treatment market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fertility drugs and the use of assisted reproductive technology (ART).

The market is divided into the following segments based on treatment type:
- ART
- Infertility drugs

Technavio's report, Fertility Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Cellcura
- CooperSurgical
- Intramed
- Ferring Pharmaceuticals
- Merck


Other prominent vendors
- Abbott Laboratories
- AbbVie
- Actavis
- Apricus Biosciences
- AstraZeneca
- Auxogyn
- Bristol-Myers Squibb
- Elelixis Diagnostics
- Eli Lilly
- EMD Serono
- IKS International
- In Vitro Care
- Invo Bioscience
- Irvine Scientific
- IVFtech Aps
- Life Global
- Medical Electronic Systems
- Meditex
- Novartis
- Ovascience
- Pantec Biosolutions
- Pfizer
- Sanofi
- Vivus
- Xytex Cryo International

Market driver
- Emergence of ART and acceptance of same-sex marriage
- For a full, detailed list, view our report

Market challenge
- High cost of fertility treatment
- For a full, detailed list, view our report

Market trend
- Increase in M&A
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Programmed Death-1 & Programmed Death Ligand-1 Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 - Industry Insights by Drug, by Mechanism of Action

Global Programmed Death-1 & Programmed Death Ligand-1 Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 - Industry Insights by Drug, by Mechanism of Action

  • $ 6500
  • Industry report
  • January 2017
  • by P&S Market Research

Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) inhibitors are the therapeutic candidates or drugs, popularly known as checkpoint inhibitors, used most commonly for the treatment of cance ...

HIV Treatment Drugs Markets in China

HIV Treatment Drugs Markets in China

  • $ 4000
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

China’s demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

Infertility Services Market in US 2017-2021

Infertility Services Market in US 2017-2021

  • $ 3500
  • Industry report
  • February 2017
  • by Infiniti Research Limited

About Infertility Services Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.